Reduction of In-Stent Restenosis Risk on Nickel-Free Stainless Steel by Regulating Cell Apoptosis and Cell Cycle

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Li, Liming ^a,b   Pan, Shuang ^a   Zhou, Xiaohang ^a   Meng, Xin ^a   Han, Xiaoxi ^a   Ren, Yibin ^c   Yang, Ke ^c   Guan, Yifu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

^c INSTITUTE OF METAL RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; BECLIN 1; CASPASE 3; CASPASE 8; CASPASE 9; CELL PROTEIN; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN A1; CYCLIN D; CYCLIN E; FAS LIGAND; PROTEIN ATG12; STAINLESS STEEL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOVASCULAR RISK; CELL ADHESION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN-STENT RESTENOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; CORONARY RESTENOSIS; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION PROFILING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; NICKEL; OPTICAL IMAGING; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; STAINLESS STEEL; STENTS;

EID: 84876873328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062193     Document Type: Article

References (45)

1. Waterhouse A, Yin Y, Wise SG, Bax DV, McKenzie DR, et al. (2010) The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents. Biomaterials 31: 8332-8340.
2. Ren L, Xu L, Feng J, Zhang Y, Yang K, (2012) In vitro study of role of trace amount of Cu release from Cu-bearing stainless steel targeting for reduction of in-stent restenosis. Journal of Materials Science: Materials in Medicine 23: 1235-1245.
3. Bauters C, Banos JL, Van Belle E, Mc Fadden EP, Lablanche JM, et al. (1998) Six-Month Angiographic Outcome After Successful Repeat Percutaneous Intervention for In-Stent Restenosis. Circulation 97: 318-321.
4. Inoue T, Node K, (2009) Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 73: 615-621.
5. Lü X, Lu H, Zhao L, Yang Y, Lu Z, (2010) Genome-wide pathways analysis of nickel ion-induced differential genes expression in fibroblasts. Biomaterials 31: 1965-1973.
6. Newby AC, Zaltsman AB, (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309.
7. McLucas E, Rochev Y, Carroll WM, Smith TJ, (2008) Analysis of the effects of surface treatments on nickel release from nitinol wires and their impact on candidate gene expression in endothelial cells. Journal of Materials Science: Materials in Medicine 19: 975-980.
8. Xia Y, Bhattacharyya A, Roszell EE, Sandig M, Mequanint K, (2012) The role of endothelial cell-bound Jagged1 in Notch3-induced human coronary artery smooth muscle cell differentiation. Biomaterials 33: 2462-2472.
9. Garg S, Serruys PW, (2010) Coronary Stents. Journal of the American College of Cardiology 56: S1-S42.
10. Garg S, Serruys P, (2010) Benefits of and safety concerns associated with drug-eluting coronary stents. Expert Rev Cardiovasc Ther 8: 449-470.
11. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, et al. (2007) Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications. Circulation 115: 1051-1058.
12. Ren Y, Wan P, Liu F, Zhang B, Yang K, (2011) In vitro Study on a New High Nitrogen Nickel-free Austenitic Stainless Steel for Coronary Stents. Journal of Materials Science & Technology 27: 325-331.
13. Yang K, Ren Y, Wan P, (2011) High nitrogen nickel-free austenitic stainless steel: A promising coronary stent material. Science China Technological Sciences 55: 329-340.
14. Iijima R, Ikari Y, Amiya E, Tanimoto S, Nakazawa G, et al. (2005) The impact of metallic allergy on stent implantation: metal allergy and recurrence of in-stent restenosis. Int J Cardiol 104: 319-325.
15. Hillen U, Haude M, Erbel R, Goos M, (2002) Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis 47: 353-356.
16. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, et al. (2000) Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356: 1895-1897.
17. Saito T, Hokimoto S, Oshima S, Noda K, Kojyo Y, et al. (2009) Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovasc Revasc Med 10: 17-22.
18. Herting G, Wallinder IO, Leygraf C, (2008) Metal release rate from AISI 316L stainless steel and pure Fe, Cr and Ni into a synthetic biological medium-a comparison. J Environ Monit 10: 1092-1098.
19. Walczak J, Shahgaldi F, Heatley F, (1998) In vivo corrosion of 316L stainless-steel hip implants: morphology and elemental compositions of corrosion products. Biomaterials 19: 229-237.
20. Gutensohn K, Beythien C, Bau J, Fenner T, Grewe P, et al. (2000) In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res 99: 577-585.
21. Halwani DO, Anderson PG, Lemons JE, Jordan WD, Anayiotos AS, et al. (2010) In-vivo corrosion and local release of metallic ions from vascular stents into surrounding tissue. J Invasive Cardiol 22: 528-535.
22. Montanaro L, Cervellati M, Campoccia D, Arciola CR, (2006) Promising in vitro performances of a new nickel-free stainless steel. J Mater Sci Mater Med 17: 267-275.
23. Sasaki M, Inoue M, Katada Y, Taguchi T, (2012) The effect of VEGF-immobilized nickel-free high-nitrogen stainless steel on viability and proliferation of vascular endothelial cells. Colloids and Surfaces B: Biointerfaces 92: 1-8.
24. Fini M, Nicoli Aldini N, Torricelli P, Giavaresi G, Borsari V, et al. (2003) A new austenitic stainless steel with negligible nickel content: an in vitro and in vivo comparative investigation. Biomaterials 24: 4929-4939.
25. Wan P, Ren Y, Zhang B, Yang K, (2010) Effect of nitrogen on blood compatibility of nickel-free high nitrogen stainless steel for biomaterial. Materials Science and Engineering: C 30: 1183-1189.
26. Shi W, Nie D, Jin G, Chen W, Xia L, et al. (2012) BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 33: 3119-3126.
27. Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A, (2010) Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ J 74: 1501-1512.
28. Bonnesen C, Nelander G-M, Hansen BF, Jensen P, Krabbe JS, et al. (2009) Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin. Cell Biology and Toxicology 26: 293-307.
29. Nayab SN, Jones FH, Olsen I, (2007) Modulation of the human bone cell cycle by calcium ion-implantation of titanium. Biomaterials 28: 38-44.
30. Alvarez K, Hyun S-K, Fujimoto S, Nakajima H, (2008) In vitro corrosion resistance of Lotus-type porous Ni-free stainless steels. Journal of Materials Science: Materials in Medicine 19: 3385-3397.
31. Evans EJ, Thomas IT, (1986) The in vitro toxicity of cobalt-chrome-molybdenum alloy and its constituent metals. Biomaterials 7: 25-29.
32. Craig RG, Hanks CT, (1990) Cytotoxicity of experimental casting alloys evaluated by cell culture tests. J Dent Res 69: 1539-1542.
33. Nagata S, (1997) Apoptosis by death factor. Cell 88: 355-365.
34. Kang PM, Izumo S, (2003) Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends in Molecular Medicine 9: 177-182.
35. Yang F, Wu W, Cao L, Huang Y, Zhu Z, et al. (2011) Pathways of macrophage apoptosis within the interface membrane in aseptic loosening of prostheses. Biomaterials 32: 9159-9167.
36. Tuleta I, Bauriedel G, Steinmetz M, Pabst S, Peuster M, et al. (2010) Apoptosis-regulated survival of primarily extravascular cells in proliferative active poststent neointima. Cardiovascular Pathology 19: 353-360.
37. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A, (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death and Differentiation 16: 966-975.
38. Chen Y, Klionsky DJ, (2010) The regulation of autophagy- unanswered questions. Journal of Cell Science 124: 161-170.
39. Thorburn A, (2007) Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13: 1-9.
40. Djavaheri-Mergny M, Maiuri MC, Kroemer G, (2010) Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29: 1717-1719.
41. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, et al. (2005) Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 280: 20722-20729.
42. Stacey DW, (2003) Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Current Opinion in Cell Biology 15: 158-163.
43. Gali-Muhtasib H, Bakkar N, (2002) Modulating cell cycle: current applications and prospects for future drug development. Curr Cancer Drug Targets 2: 309-336.
44. Lamberti M, Perfetto B, Costabile T, Canozo N, Baroni A, et al. (2004) In vitro evaluation of matrix metalloproteinases as predictive testing for nickel, a model sensitizing agent. Toxicol Appl Pharmacol 195: 321-330.
45. Lü X, Bao X, Huang Y, Qu Y, Lu H, et al. (2009) Mechanisms of cytotoxicity of nickel ions based on gene expression profiles. Biomaterials 30: 141-148.